We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stent-Assisted Angioplasty Aids Stroke Symptoms

By HospiMedica staff writers
Posted on 11 Jun 2001
A study has shown that stent-assisted angioplasty may alleviate symptoms, increase blood flow to the brain, and improve the prognosis of patients with stroke symptoms from arterial blockages in the rear of the brain. More...
The retrospective study was published in the June 2001 issue of Neurosurgery.

The study was conducted by researchers from the University of Pittsburgh (UPMC, PA, USA) and the University of Texas Southwestern Medical Center (Dallas, USA). The researchers examined the outcomes of 11 patients with stroke symptoms who underwent angioplasty and stenting of either the vertebral or basilar arteries. All of the patients had transient ischemic attacks or fixed deficits that failed to respond to medical treatment. Symptoms included headache, facial droop, loss of coordination, vertigo, and depression. After a follow-up of four months, seven of the patients no longer had recurrent symptoms, lived at home, and resumed activities at the same or better levels than before. The remaining four patients died either from complications during the procedure or several months later.

The researchers note that for surgical management of basilar or vertebral stenosis, the combined mortality and morbidity rate is 34%, while angioplasty of these arteries without stenting leads to restenosis in 20-30% of patients. Recent advances in stent technology have led to the development of a new generation of stents that allow neuroradiologists to better negotiate the arteries in the back of the neck.

"Although this study demonstrates the potential for stent-assisted angioplasty, it also demonstrates the risks associated with dilation of stenotic, often fragile, diseased vessels,” said Michael Horowitz, M.D., UPMC associate professor in the department of neurological surgery and radiology. "Long-term follow-up is needed to determine whether this treatment will improve on the natural history of the disease with medical management alone.”





Related Links:
Univ. of Pittsburgh
Univ. of Texas

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.